Emerging drugs for chronic urticaria

Riccardo Asero, Alberto Tedeschi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chronic urticaria (CU), with or without angioedema, is a frequent disorder defined as the occurrence of pruritic wheals for > 6 weeks. Studies carried out in the last two decades showed that the origin of the disease is autoimmune in up to 50% of cases. Currently available treatments include antihistamines, corticosteroids and ciclosporin; recently, leukotriene receptor antagonists proved effective in a subset of patients as well. For patients with an unremitting and extremely severe disease unresponsive to standard treatments, plasmapheresis and immunosuppressive drugs have been successfully attempted. Recent findings that the autologous plasma skin test scores positive in nearly all patients and that plasmas from patients with both autoimmune and 'idiopathic' chronic urticaria are frequently characterised by signs of thrombin activation (plasma levels of prothrombin fragment F1.2 are significantly increased) suggest that clotting cascade might be somehow involved in the pathogenesis of CU. These findings put under a new light some rather sparse studies of the effect of drugs active on the coagulation system (heparin and oral anticoagulants) in patients with CU.

Original languageEnglish
Pages (from-to)265-274
Number of pages10
JournalExpert Opinion on Emerging Drugs
Volume11
Issue number2
DOIs
Publication statusPublished - May 2006

Fingerprint

Urticaria
Pharmaceutical Preparations
Leukotriene Antagonists
Angioedema
Plasmapheresis
Histamine Antagonists
Prothrombin
Immunosuppressive Agents
Skin Tests
Thrombin
Anticoagulants
Cyclosporine
Autoimmune Diseases
Heparin
Adrenal Cortex Hormones
Light
Therapeutics

Keywords

  • Anticoagulants
  • Chronic urticaria
  • Heparin
  • Therapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Emerging drugs for chronic urticaria. / Asero, Riccardo; Tedeschi, Alberto.

In: Expert Opinion on Emerging Drugs, Vol. 11, No. 2, 05.2006, p. 265-274.

Research output: Contribution to journalArticle

Asero, Riccardo ; Tedeschi, Alberto. / Emerging drugs for chronic urticaria. In: Expert Opinion on Emerging Drugs. 2006 ; Vol. 11, No. 2. pp. 265-274.
@article{a6f1b4686e7f47c4913ab47974ef3156,
title = "Emerging drugs for chronic urticaria",
abstract = "Chronic urticaria (CU), with or without angioedema, is a frequent disorder defined as the occurrence of pruritic wheals for > 6 weeks. Studies carried out in the last two decades showed that the origin of the disease is autoimmune in up to 50{\%} of cases. Currently available treatments include antihistamines, corticosteroids and ciclosporin; recently, leukotriene receptor antagonists proved effective in a subset of patients as well. For patients with an unremitting and extremely severe disease unresponsive to standard treatments, plasmapheresis and immunosuppressive drugs have been successfully attempted. Recent findings that the autologous plasma skin test scores positive in nearly all patients and that plasmas from patients with both autoimmune and 'idiopathic' chronic urticaria are frequently characterised by signs of thrombin activation (plasma levels of prothrombin fragment F1.2 are significantly increased) suggest that clotting cascade might be somehow involved in the pathogenesis of CU. These findings put under a new light some rather sparse studies of the effect of drugs active on the coagulation system (heparin and oral anticoagulants) in patients with CU.",
keywords = "Anticoagulants, Chronic urticaria, Heparin, Therapy",
author = "Riccardo Asero and Alberto Tedeschi",
year = "2006",
month = "5",
doi = "10.1517/14728214.11.2.265",
language = "English",
volume = "11",
pages = "265--274",
journal = "Expert Opinion on Emerging Drugs",
issn = "1472-8214",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Emerging drugs for chronic urticaria

AU - Asero, Riccardo

AU - Tedeschi, Alberto

PY - 2006/5

Y1 - 2006/5

N2 - Chronic urticaria (CU), with or without angioedema, is a frequent disorder defined as the occurrence of pruritic wheals for > 6 weeks. Studies carried out in the last two decades showed that the origin of the disease is autoimmune in up to 50% of cases. Currently available treatments include antihistamines, corticosteroids and ciclosporin; recently, leukotriene receptor antagonists proved effective in a subset of patients as well. For patients with an unremitting and extremely severe disease unresponsive to standard treatments, plasmapheresis and immunosuppressive drugs have been successfully attempted. Recent findings that the autologous plasma skin test scores positive in nearly all patients and that plasmas from patients with both autoimmune and 'idiopathic' chronic urticaria are frequently characterised by signs of thrombin activation (plasma levels of prothrombin fragment F1.2 are significantly increased) suggest that clotting cascade might be somehow involved in the pathogenesis of CU. These findings put under a new light some rather sparse studies of the effect of drugs active on the coagulation system (heparin and oral anticoagulants) in patients with CU.

AB - Chronic urticaria (CU), with or without angioedema, is a frequent disorder defined as the occurrence of pruritic wheals for > 6 weeks. Studies carried out in the last two decades showed that the origin of the disease is autoimmune in up to 50% of cases. Currently available treatments include antihistamines, corticosteroids and ciclosporin; recently, leukotriene receptor antagonists proved effective in a subset of patients as well. For patients with an unremitting and extremely severe disease unresponsive to standard treatments, plasmapheresis and immunosuppressive drugs have been successfully attempted. Recent findings that the autologous plasma skin test scores positive in nearly all patients and that plasmas from patients with both autoimmune and 'idiopathic' chronic urticaria are frequently characterised by signs of thrombin activation (plasma levels of prothrombin fragment F1.2 are significantly increased) suggest that clotting cascade might be somehow involved in the pathogenesis of CU. These findings put under a new light some rather sparse studies of the effect of drugs active on the coagulation system (heparin and oral anticoagulants) in patients with CU.

KW - Anticoagulants

KW - Chronic urticaria

KW - Heparin

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33646595383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646595383&partnerID=8YFLogxK

U2 - 10.1517/14728214.11.2.265

DO - 10.1517/14728214.11.2.265

M3 - Article

C2 - 16634701

AN - SCOPUS:33646595383

VL - 11

SP - 265

EP - 274

JO - Expert Opinion on Emerging Drugs

JF - Expert Opinion on Emerging Drugs

SN - 1472-8214

IS - 2

ER -